Get the app!
Back to Trades

Rubenstein David M.

DirectorCIK 0001543895

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
5
Buy transactions
0
Sell transactions
3
Companies
2
Active
2025–2026

Rubenstein David M., Director, has filed 5 SEC reports (2025–2026), spread across 2 companies, totaling $76.3M in disclosed volume. Weighing $0 bought versus $75.8M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

5 loaded
Sep 11CG
Carlyle Group Inc.
Rubenstein David M.DirectorSell$17.1M
May 8MRNA
Moderna, Inc.
Rubenstein David M.DirectorAward$472.3K
Mar 20CG
Carlyle Group Inc.
Rubenstein David M.DirectorSell$23.3M
Dec 12CG
Carlyle Group Inc.
Rubenstein David M.DirectorSell$35.3M
Aug 6MRNA
Moderna, Inc.
Rubenstein David M.DirectorExercise$0

5 filings